Clinical Trials on Cervical Cancer in New Zealand
Total 7879 results
-
National Cancer Institute (NCI)National Institutes of Health (NIH)CompletedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterCompletedGastric Cancer | Colorectal Cancer | Esophageal Cancer | Small Bowel Cancer | Appendix Cancer | Ampullary CancerUnited States
-
Onconova Therapeutics, Inc.CompletedNeoplasms | Cancer | Advanced Cancer | Solid TumorsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Carcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast CarcinomaUnited States
-
Xencor, Inc.ICON plcRecruitingOvarian Cancer | Endometrial Cancer | Cervical Carcinoma | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Clear Cell CarcinomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedStage II Uterine Corpus Cancer | Stage IA Uterine Corpus Cancer | Stage IB Uterine Corpus Cancer | Stage IIIA Uterine Corpus Cancer | Stage IIIB Uterine Corpus Cancer | Stage IIIC Uterine Corpus Cancer | Stage IVA Uterine Corpus Cancer | Stage IVB Uterine Corpus CancerUnited States
-
Monika Joshi, MDAstraZenecaActive, not recruiting
-
Galectin Therapeutics Inc.CompletedBreast Cancer | Head and Neck Cancer | Colorectal Cancer | Lung Cancer | Prostate CancerUnited States
-
Matthew GalskyBristol-Myers Squibb; Hoosier Cancer Research NetworkActive, not recruitingMetastatic Urothelial CancerUnited States
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedStage II Gallbladder Cancer | Stage IIIA Gallbladder Cancer | Stage IIIB Gallbladder Cancer | Stage IVA Gallbladder Cancer | Stage IVB Gallbladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAmerican Cancer Society, Inc.Active, not recruiting
-
Apricity Health, LLCRecruiting
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterGeorgetown University; National Institute of Standards and TechnologyCompleted
-
All India Institute of Medical Sciences, New DelhiUnknown
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Genentech, Inc.CompletedNon-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Metastatic Non Small Cell Lung Cancer, Metastatic Cancers, MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
Memorial Sloan Kettering Cancer CenterTerminated
-
Tavotek BiotherapeuticsRecruiting
-
New York UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Recruiting
-
Columbia UniversityActive, not recruiting
-
Weill Medical College of Cornell UniversityTerminated
-
New York Medical CollegeTerminated
-
NYU Langone HealthCompleted
-
Memorial Sloan Kettering Cancer CenterNova Biomedical CorporationCompletedCancerUnited States
-
National Center for Research Resources (NCRR)Unknown
-
Mridula George, MDNational Cancer Institute (NCI); Incyte Corporation; Oncolytics BiotechRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Triple-negative Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States
-
IpsenCompletedCervical DystoniaUnited States, Russian Federation
-
Columbia UniversityRecruitingAbdominal Cancer | Pelvic CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedBladder Cancer | Ureter Cancer | Renal Pelvis CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Gynecologic CancerUnited States
-
Dartmouth-Hitchcock Medical CenterRecruitingColorectal Cancer | Small Bowel Cancer | Appendix Cancer | Esophagus Cancer | Ampullary CancerUnited States
-
Esanex Inc.Terminated
-
Roswell Park Cancer InstituteNational Center for Advancing Translational Sciences (NCATS)CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterBayerCompletedGastric Cancer | Esophageal CancerUnited States
-
Roswell Park Cancer InstituteAIM ImmunoTech Inc.SuspendedProstate Adenocarcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer... and other conditionsUnited States
-
Surgical Outcomes Research Centre (SOuRCe)RecruitingGastric Cancer | Colorectal Cancer | Pancreas Cancer | Liver Cancer | Oesophageal CancerAustralia
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage IIIUnited States
-
Memorial Sloan Kettering Cancer CenterFox Chase Cancer Center; University of ChicagoRecruitingBladder Cancer | Urothelial Cancer | Ureter Cancer | Renal Pelvis CancerUnited States
-
Fate TherapeuticsTerminatedMelanoma | Lymphoma | Renal Cell Carcinoma | Cervical Cancer | Head and Neck Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | NSCLC | Advanced Solid Tumor | Small-cell Lung Cancer | HER2-positive Breast Cancer | Pancreas Cancer | Urothelial Carcinoma | Merkel Cell Carcinoma | Microsatellite Instability and other conditionsUnited States
-
Rutgers, The State University of New JerseyColorado Department of Public Health and Environment; University of New MexicoCompletedBreast Cancer | Ovarian CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Ovarian Carcinoma | Primary Peritoneal Carcinoma | Stage IV Fallopian Tube Cancer | Stage IV Ovarian Cancer | Stage III Ovarian Cancer | Stage III Fallopian Tube Cancer | Stage II Ovary Cancer | Stage II Ovarian Cancer | Stage III Ovary Cancer and other conditionsUnited States
-
Kymab LimitedSanofiActive, not recruitingMelanoma | Renal Cell Carcinoma | Cervical Cancer | Hepatocellular Carcinoma | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Metastatic Cancer | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Advanced CancerUnited States, Hungary, Italy, Poland, Taiwan, United Kingdom
-
Ontario Clinical Oncology Group (OCOG)Canadian Institutes of Health Research (CIHR); Canadian Breast Cancer Research...CompletedBreast CancerCanada, Australia, New Zealand
-
Memorial Sloan Kettering Cancer CenterCompleted